Home / Conference Details / Speakers
Associate Professor Roy ChaN - Unfortunately Professor Chan is no longer able to attend the IUSTI Congress.
The IUSTI World Congress is renowned for attracting distinguished speakers from around the world. With the 2012 World Congress being held in conjunction with the 2012 Australasian Sexual Health Conference, there will be a plethora of international and Australasian based speakers on offer.
In 2012 we are pleased to welcome:
From USA, UK, New Zealand, South Africa and Singapore
Dr Sevgi Aral (USA)
Clinical Professor, University of Washington School of Medicine, Associate Director for Science, Division of STD Prevention, Centers for Disease Control and Prevention (CDC), USA
Professor Jonathan Ross
Professor Sexual Health and HIV, University Hospital Birmingham, Birmingham, UK
Professor King Holmes (USA)
Chair, Global Health, Professor, Department of Medicine, Professor, Global Health, Adjunct Professor, Epidemiology, School of Public Health, University of Washington, USA.
Professor David Lewis (South Africa)
IUSTI World President Elect and IUSTI Regional Director Africa, Head, Centre for HIV and Sexually Transmitted Infections, National Institute of Communicable Diseases, National Health Laboratory Service, South Africa.
Professor Tom Quinn (USA)
Professor of Medicine and Director, Center for Global Health, Johns Hopkins University Associate Director of International Research, and Head of the Section on International HIV/STD Research, NIAID, NIH
Dr Raj Patel (UK)
President- IUSTI, Genito Urinary Medicine, The Royal South Hants Hospital, England.
Marama Pala (New Zealand)
Executive Director of INA (Māori, Indigenous & South Pacific) HIV/AIDS Foundation, New Zealand
Professor Suzanne Garland (Australia)
Department of Microbiology and Infectious Diseases, Royal Women’s Hospital, Melbourne, Department of Obstetrics and Gynaecology,
The University of Melbourne, Australia
Dr Sevgi Aral
Sevgi Okten Aral, MA, MS, PhD has been the Associate Director for Science in the Division of STD Prevention, Centers for Disease Control since 1993. She holds Professorial appointments at the University Of Washington in Seattle; University of Manitoba in Winnipeg and Emory University in Atlanta.
Dr. Aral has authored more than 230 scientific articles and edited 16 journal issues and 2 books. Dr. Aral has served on many national and international work groups, boards and committees; and has consulted for the World Health Organization, The European Union and the World Bank. She has received the ASTDA Achievement Award and the Thomas Parran Award.
Over the years, her research interests have included social and behavioral aspects of sexually transmitted disease epidemiology and prevention; including gender, age and race effects; mixing patterns; sexual and social networks; contextual factors; social determinants and most recently, program science.
Dr. Aral came to the Centers for Disease Control from Middle East Technical University in Ankara, Turkey where she was the chair of the Department of Social Sciences.
Professor Jonathan Ross
Professor Jonathan Ross is Professor of Sexual Health and HIV. He qualified from Aberdeen University Medical School in 1986 and worked in general medicine and genitourinary medicine, being dually accredited in 1997. He has worked as a consultant physician in sexual health and HIV medicine in Birmingham since 1997.
He is treasurer for the British Association for Sexual Health and HIV, editor of STD Global Update and sits on the IUSTI World Executive committee. He is also an associate editor of the journal Sexually Transmitted Infections, a member of the editorial board for European Sexually Transmitted Diseases Guidelines and chairman of the Neurolgy Specialty Question Group for the MRCP examination.
Professor Ross is the author of UK and European Guidelines on Pelvic Inflammatory Disease and editor of the UK National Screening and Testing Guidelines for STDs. He is on the Editorial Board of the Cochrane Collaboration Sexually Transmitted Diseases Collaborative Review Group and International Journal of STD and AIDS journal. His research interests are pelvic infection, HIV and sexual health care service delivery.
Professor King Holmes
Dr. King Holmes became the first William H. Foege Chair of Global Health at the University of Washington effective November 1, 2006, and also is Professor of Global Health, Medicine, Microbiology, and Epidemiology. He formerly served as Chief of Medicine and heads the Infectious Diseases Section at Harborview Medical Center; founded and directs the UW Center for AIDS and STD, a WHO Collaborating Center for AIDS and STD; and is Principal Investigator for the International Training & Education Center for Health (I-TECH), a collaboration between the UW and University of California, San Francisco, with programs in 30 countries. He served as President of IUSTI, co-founded the International Society for STD Research (ISSTDR), and is a member of the Institute of Medicine of the National Academy of Science. He has trained and/or mentored over 100 scientists. He has edited 30 books and manuscripts, and has published 700 research papers on infectious diseases, most concerning STDs.
Professor David Lewis
Professor Lewis is Head of the Centre for HIV and Sexually Transmitted Infections at the National Institute for Communicable Diseases, a Division of the National Health Laboratory Service in Johannesburg, South Africa. He holds honorary professorial appointments at the Universities of the Witwatersrand and Cape Town. He has worked in the field of HIV/STIs since 1989, both as a clinician and a microbiologist. His current work involves both HIV/STI research and surveillance in Southern Africa and his research interests focus on gonorrhoea, genital ulceration and men’s sexual health. He recently assisted with STI guideline revisions in South Africa, Namibia and for the Southern African Development Community (SADC). In collaboration with the World Health Organisation, he led the development of the African Gonococcal Antimicrobial Susceptibility Programme (Afro-GASP) from 2010-2012. Professor Lewis serves as an ISSTDR Board Member, IUSTI World President Elect, Regional Director for IUSTI-Africa, an Assistant Editor for Sexually Transmitted Infections and a Joint Editor for 'Sexual Health'.
Professor Tom Quinn
Tom Quinn MD, MSc is Senior Investigator and Head of the Section on International HIV/AIDS Research in the Laboratory of Immunoregulation at the National Institute of Allergy and Infectious Diseases. He also serves as Associate Director for International Research for the Division of Intramural Research at NIAID. He is also Professor of Medicine and Pathology in the Johns Hopkins School of Medicine and has adjunct appointments in the Departments of International Health, Epidemiology, and Molecular Microbiology and Immunology in The Johns Hopkins School of Public Health. In 2006 he was appointed Director of the Johns Hopkins Center for Global Health.
Dr. Quinn has been involved in HIV clinical and epidemiologic investigations in 25 countries, with current projects in Uganda, Zimbabwe, Tanzania, India, China, and Thailand. Among his professional activities, Dr. Quinn has been an Advisor/Consultant on HIV and STDs to the World Health Organization, Office of the Global AIDS Coordinator (PEPFAR), UNAIDS, and the U.S. Food and Drug Administration. In 2004 he became a member of the Institute of Medicine of the National Academy of Science. In 2007 he was elected as fellow of the American Association for the Advancement of Science. He is also a fellow of the Infectious Disease Society of America and a member of the American Association of Physicians. He is an author of approximately 900 publications on HIV, STDs, and infectious diseases.
Dr Raj Patel
Dr Raj Patel, is a Consultant Physician specialising in Sexual Health and HIV medicine working within the UK NHS. He also holds a Senior Lecturer post at the University of Southampton. He has developed a major research interest in HSV infections and has held a number of key appointments within the UK around the development , delivery and assessment of postgraduate specialist training.
Marama Pala (Ngātiawa), BML, BMA, AdvDip, the Executive Director of INA (Māori, Indigenous & South Pacific) HIV/AIDS Foundation, an organization that provides prevention, advocacy and support services to Māori. Marama is the Co-Chair of the International Indigenous Working Group on HIV & AIDS (IIWGHA) involving Indigenous Communities around the world in the fight against HIV & AIDS. Marama Pala contracted HIV in 1993 and was the first Māori woman to publicly disclose her HIV status; she became a powerful advocate for Māori and marginalized communities. As a key witness in a successful criminal HIV transmission case (P, Mwai 1993), she is now a courageous advocate against the use of criminal law to persecute people living with HIV. She was appointed as one of seven Global Community representatives on the Community Programme Committee for the 19th International AIDS Conference 2012 in Washington DC. Marama has been a keynote speaker globally.
Professor Suzanne Garland
Professor Garland is an internationally recognized clinical microbiologist and sexual health physician, with particular expertise in infectious diseases as they pertain to reproductive health and the neonate. With her team, Prof Garland, has been a leader in the role of patient self-collected genital sampling in the detection by molecular techniques (polymerase chain reaction (PCR) of reproductive tract infections, particularly those sexually transmitted, such as Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis and herpes simplex virus and have published extensively on clinical epidemiology of sexually transmitted infections in Australia. In addition, a key area of research interest is cervical cancer and the role of human papillomaviruses (HPV). She has been involved in defining HPV in cervical dysplasia, cervical cancer, plus the healthy population within Australia, as well as being chief investigator defining the prevalence of HPV genotypes in urban, rural, indigenous and non-indigenous Australian women (WHINURS project). She has been chief investigator of two 4-year follow-up clinical trials of prophylactic HPV vaccines in young women, and currently one in mid-age women. She currently leads an HPV vaccine effectiveness trial in Australia which will be informative globally.
She is a regular Advisor to the WHO, largely in the area of sexually transmitted infection diagnosis, for prophylactic HPV vaccines, as well as international standards for HPV DNA assays. She has published extensively in more than 393 peer-reviewed journals, as well as being invited to deliver keynote and plenary presentations at national and international meetings. She is the Inaugural and Past President of the newly formed society, AOGIN (Asian Oceania Research Organization on Genital Infection and Neoplasia), which brings together clinicians and scientists within the Asian and Oceania regions and whose work is related to genital infections and neoplasia. AOGIN aims to promote and develop, at an Asia-Oceania level, research, training, screening, prevention and information concerning genital infections, pre-cancers and cancers in women and brings together representatives from the Asia-Oceania region, of a multidisciplinary specialist areas including: gynaecologists, sexual health physicians, dermatologists, pathologists, molecular biologists, oncologists and basic scientists. In recognition of her clinically based research Infectious Diseases Research in Reproductive Health; Particularly of Women and Babies" Prof Garland was selected to in 2010 by NHMRC for “one of the 10 Best Research Projects".